Compounding pharmacy remains a sector that competes on innovation, clinical value, and service—not price. Businesses that compete primarily on price simply rearrange the deck chairs on the Titanic. Customer relationships and provider trust drive enterprise value. Sellers must clearly understand the core assets of their company and how the market values them—because when buyers control the narrative, sellers lose leverage.
